Cargando…
Reply to Letter to the Editor: “Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?”
Autores principales: | Dindaş, Ferhat, Güngör, Hüseyin, Ekici, Mehmet, Akokay, Pınar, Erhan, Füsun, Doğduş, Mustafa, Birhan Yılmaz, Mehmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Society of Cardiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366426/ https://www.ncbi.nlm.nih.gov/pubmed/35435851 http://dx.doi.org/10.5152/AnatolJCardiol.2021.1371 |
Ejemplares similares
-
Reply to Letter to the Editor: “Atrial Function Assessment in High-Risk Hypertrophic Cardiomyopathy”
por: Candan, Özkan, et al.
Publicado: (2023) -
Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?
por: Özgür Barış, Veysel, et al.
Publicado: (2022) -
Authors reply to letter to the editor
por: Al-Essa, Rakan S., et al.
Publicado: (2023) -
Letters to the Editor / Author’s reply
por: Ozdemir, Mikail, et al.
Publicado: (2022) -
Reply: “Letter to the Editor Re: Billeaud et al. Nutrients 2018, 10, 690”
por: Billeaud, Claude, et al.
Publicado: (2019)